PubMed

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

Peterson BA, Petroni GR, Frizzera G, Barcos M, Bloomfield CD, Nissen NI, Hurd DD, Henderson ES, Sartiano GP, Johnson JL, Holland JF, Gottlieb AJ.

J Clin Oncol. 2003 Jan 1;21(1):5-15.PMID: 12506163 [PubMed - indexed for MEDLINE]Related articles

S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Brown PD, Diamant M, Jensen PO, Geisler CH, Mortensen BT, Nissen NI.

Leuk Lymphoma. 1999 Jul;34(3-4):325-33.PMID: 10439369 [PubMed - indexed for MEDLINE]Related articles

S-phase induction by interleukin-6 followed by chemotherapy in patients with refractory multiple myeloma.

de Nully Brown P, Jensen PO, Diamant M, Mortensen BT, Hovgaard D, Gimsing P, Nissen NI.

Leuk Res. 1998 Nov;22(11):983-9.PMID: 9783799 [PubMed - indexed for MEDLINE]Related articles

[Campath-1H--a monoclonal antibody for treatment of non-Hodgkin's and chronic lymphatic leukemia]

de Nully Brown P, Hansen MM, Nissen NI.

Ugeskr Laeger. 1997 Jul 7;159(28):4389-93. Danish. PMID: 9235735 [PubMed - indexed for MEDLINE]Related articles

The in vivo effects of interleukin-3 on histamine levels in non-Hodgkin's lymphoma patients.

Hovgaard DJ, Stahl Skov P, Nissen NI.

Pharmacol Toxicol. 1997 Jun;80(6):290-4.PMID: 9225366 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin-3 following chemotherapy for non-Hodgkin's lymphoma.

Hovgaard DJ, Mortensen BT, Nissen NI.

Br J Haematol. 1995 Oct;91(2):367-73.PMID: 8547077 [PubMed - indexed for MEDLINE]Related articles

Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.

Hovgaard DJ, Nissen NI.

Eur J Haematol. 1995 Feb;54(2):78-84.PMID: 7698300 [PubMed - indexed for MEDLINE]Related articles

Recombinant human interleukin-3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics.

Hovgaard DJ, Folke M, Mortensen BT, Nissen NI.

Br J Haematol. 1994 Aug;87(4):700-7.PMID: 7986709 [PubMed - indexed for MEDLINE]Related articles

[Ultrasound and lymphography in malignant lymphoma. Comparison with consideration to staging]

Bang N, Vejborg IM, Lollike K, Nissen NI, Pedersen KL.

Ugeskr Laeger. 1994 May 2;156(18):2741-3. Danish. PMID: 8009714 [PubMed - indexed for MEDLINE]Related articles

Development and application of a sensitive radioimmunoassay for human granulocyte-macrophage colony-stimulating factor able to measure normal concentrations in blood.

Mortensen BT, Schifter S, Pedersen LB, Jensen AN, Hovgaard D, Nissen NI.

Exp Hematol. 1993 Sep;21(10):1366-70.PMID: 8359236 [PubMed - indexed for MEDLINE]Related articles

Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B.

Mir R, Anderson J, Strauchen J, Nissen NI, Cooper MR, Rafla S, Canellos GP, Bloomfield CD, Gottlieb AJ, Peterson B, et al.

Cancer. 1993 Mar 1;71(5):1857-66.PMID: 8448750 [PubMed - indexed for MEDLINE]Related articles

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.

Friche E, Demant EJ, Sehested M, Nissen NI.

Br J Cancer. 1993 Feb;67(2):226-31.PMID: 8094288 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor.

Hovgaard D, Mortensen BT, Schifter S, Nissen NI.

Eur J Haematol. 1993 Jan;50(1):32-6.PMID: 8436212 [PubMed - indexed for MEDLINE]Related articles

Mitoxantrone in the treatment of chronic lymphocytic leukemia.

Hansen MM, Hansen SW, Pedersen-Bjergaard J, Nissen NI.

Leuk Lymphoma. 1992 Jul;7(4):305-7.PMID: 1493430 [PubMed - indexed for MEDLINE]Related articles

A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas.

Hovgaard D, Nissen NI.

Leuk Lymphoma. 1992 Jun;7(3):217-24.PMID: 1477649 [PubMed - indexed for MEDLINE]Related articles

In vivo kinetics of 111indium-labelled autologous granulocytes following i.v. administration of granulocyte-macrophage colony-stimulating factor (GM-CSF).

Hovgaard D, Schifter S, Rabøl A, Mortensen BT, Nissen NI.

Eur J Haematol. 1992 Apr;48(4):202-7.PMID: 1592100 [PubMed - indexed for MEDLINE]Related articles

Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.

Hovgaard DJ, Nissen NI.

J Clin Oncol. 1992 Mar;10(3):390-7.PMID: 1740678 [PubMed - indexed for MEDLINE]Related articles

Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.

Friche E, Jensen PB, Nissen NI.

Cancer Chemother Pharmacol. 1992;30(3):235-7.PMID: 1628375 [PubMed - indexed for MEDLINE]Related articles

Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF.

Hovgaard D, Mortensen BT, Schifter S, Nissen NI.

Eur J Clin Invest. 1992 Jan;22(1):45-9.PMID: 1559542 [PubMed - indexed for MEDLINE]Related articles

[Malignant hematologic diseases. Diagnosis and treatment. A clearing report]

Birgens H, Christensen BE, Hansen NE, Jensen MK, Junker K, Jørgensen FS, Nielsen JL, Nissen NI.

Ugeskr Laeger. 1991 Jun 3;153(23):1638-47. Danish. PMID: 2058026 [PubMed - indexed for MEDLINE]Related articles

Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma.

Kharazmi A, Nielsen H, Hovgaard D, Borregaard N, Nissen NI.

Eur J Clin Invest. 1991 Apr;21(2):219-24.PMID: 1905635 [PubMed - indexed for MEDLINE]Related articles

Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark.

Lauritzen AF, Specht LK, Nissen NI, Hou-Jensen K.

Dan Med Bull. 1991 Feb;38(1):84-7.PMID: 2026054 [PubMed - indexed for MEDLINE]Related articles

Controversies in the management of Hodgkin's disease.

Nissen NI, Hovgaard D.

Eur J Cancer. 1991;27(3):306-9. Review. No abstract available. PMID: 1827322 [PubMed - indexed for MEDLINE]Related articles

High activity of daily-schedule mitoxantrone in newly diagnosed low-grade non-Hodgkin's lymphomas: a 5-year follow-up.

Nissen NI, Hansen SW.

Semin Oncol. 1990 Dec;17(6 Suppl 10):10-2; discussion 12-3.PMID: 2259917 [PubMed - indexed for MEDLINE]Related articles

Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.

Jensen BV, Carlsen NL, Nissen NI.

Eur Respir J. 1990 Nov;3(10):1140-5.PMID: 2090476 [PubMed - indexed for MEDLINE]Related articles

Oral idarubicin in elderly patients with acute myeloid leukemia.

Keldsen N, Karle H, Hansen NE, Nissen NI.

Eur J Haematol. 1990 Jul;45(1):60. No abstract available. PMID: 2379565 [PubMed - indexed for MEDLINE]Related articles

In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analogues.

Friche E, Jensen PB, Roed H, Skovsgaard T, Nissen NI.

Biochem Pharmacol. 1990 Jun 1;39(11):1721-6.PMID: 2344368 [PubMed - indexed for MEDLINE]Related articles

Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.

Specht L, Lauritzen AF, Nordentoft AM, Andersen PK, Christensen BE, Hippe E, Hou-Jensen K, Nissen NI.

Cancer. 1990 Jun 1;65(11):2594-601.PMID: 2337876 [PubMed - indexed for MEDLINE]Related articles

Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease.

Jensen BV, Carlsen NL, Groth S, Nissen NI.

Eur J Haematol. 1990 Mar;44(3):165-71.PMID: 2328789 [PubMed - indexed for MEDLINE]Related articles

A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria.

Schultz HB, Ersbøll J, Nissen NI, Hou-Jensen K.

Cancer. 1989 Dec 15;64(12):2532-40.PMID: 2819662 [PubMed - indexed for MEDLINE]Related articles

[Hodgkin's disease--a histologic problem]

Lauritzen AF, Specht L, Nissen NI, Hou-Jensen K.

Ugeskr Laeger. 1989 Nov 20;151(47):3138-40. Review. Danish. PMID: 2688235 [PubMed - indexed for MEDLINE]Related articles

Human immunodeficiency virus (HIV) antibody testing in 862 patients with lymphoma and leukaemia attending a department of haematology (1984-1988)

Lindhardt BO, Ulrich K, Nissen NI, Pedersen C, Skinhøj P.

Eur J Haematol. 1989 Aug;43(2):186-7. No abstract available. PMID: 2792328 [PubMed - indexed for MEDLINE]Related articles

Hodgkin's disease and age.

Specht L, Nissen NI.

Eur J Haematol. 1989 Aug;43(2):127-35.PMID: 2792320 [PubMed - indexed for MEDLINE]Related articles

Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression.

Ersbøll J, Schultz HB, Pedersen-Bjergaard J, Nissen NI.

Eur J Haematol. 1989 Feb;42(2):155-63.PMID: 2917634 [PubMed - indexed for MEDLINE]Related articles

Anthracycline resistance.

Friche E, Skovsgaard T, Nissen NI.

Acta Oncol. 1989;28(6):877-81. Review.PMID: 2692650 [PubMed - indexed for MEDLINE]Related articles

Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988.

Juliusson G, Abrahamsen AF, Cavallin-Ståhl E, Goldstone AH, Lister TA, Nissen NI, Robèrt KH, Singer CR, Somers R, Ost A, et al.

Acta Oncol. 1989;28(1):135-40. Review.PMID: 2650721 [PubMed - indexed for MEDLINE]Related articles

[Acute non-lymphocytic leukemia (ANLL) in adults. Therapeutic criteria and their consequences]

Plesner AM, Friis H, Mortensen BT, Geisler C, Hansen MM, Nissen NI.

Ugeskr Laeger. 1988 Oct 31;150(44):2652-5. Danish. No abstract available. PMID: 3059640 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors in Hodgkin's disease stage IV.

Specht L, Nissen NI.

Eur J Haematol. 1988 Oct;41(4):359-67.PMID: 3197822 [PubMed - indexed for MEDLINE]Related articles

[Medical treatment of cancer--an elucidating report]

Dombernowsky P, Hansen HH, Hansen NE, Mouridsen H, Nissen NI, Rørth M.

Ugeskr Laeger. 1988 Sep 5;150(36):2106-13. Danish. No abstract available. PMID: 3188266 [PubMed - indexed for MEDLINE]Related articles

High-risk AML evidenced by a monoclonal antibody.

Avnstrøm S, Ralfkiaer E, Hansen NE, Nissen NI.

Eur J Haematol. 1988 Aug;41(2):156-62.PMID: 3165866 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.

Specht L, Nissen NI.

Eur J Haematol. 1988 Jul;41(1):80-7.PMID: 3402591 [PubMed - indexed for MEDLINE]Related articles

Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.

Specht L, Nissen NI.

Eur J Haematol. 1988 May;40(5):396-402.PMID: 3378595 [PubMed - indexed for MEDLINE]Related articles

Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.

Pedersen-Bjergaard J, Ersbøll J, Hansen VL, Sørensen BL, Christoffersen K, Hou-Jensen K, Nissen NI, Knudsen JB, Hansen MM.

N Engl J Med. 1988 Apr 21;318(16):1028-32.PMID: 3352696 [PubMed - indexed for MEDLINE]Related articles

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.

Specht L, Nordentoft AM, Cold S, Clausen NT, Nissen NI.

Cancer. 1988 Apr 15;61(8):1719-27.PMID: 3349432 [PubMed - indexed for MEDLINE]Related articles

Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?

Pedersen-Bjergaard J, Philip P, Ravn V, Hansen SW, Nissen NI.

J Clin Oncol. 1988 Feb;6(2):395-7. Review. No abstract available. PMID: 3276828 [PubMed - indexed for MEDLINE]Related articles

High activity of mitoxantrone in previously untreated low-grade lymphomas.

Hansen SW, Nissen NI, Hansen MM, Hou-Jensen K, Pedersen-Bjergaard J.

Cancer Chemother Pharmacol. 1988;22(1):77-9.PMID: 3396148 [PubMed - indexed for MEDLINE]Related articles

Bacteremia and candidemia in hematological malignancies: clinical findings.

Hovgaard D, Skinhøj P, Bangsborg J, Bruun B, Mørk Hansen M, Nissen NI.

Scand J Infect Dis. 1988;20(5):495-501.PMID: 3222666 [PubMed - indexed for MEDLINE]Related articles

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

Pedersen-Bjergaard J, Specht L, Larsen SO, Ersbøll J, Struck J, Hansen MM, Hansen HH, Nissen NI.

Lancet. 1987 Jul 11;2(8550):83-8.PMID: 2885581 [PubMed - indexed for MEDLINE]Related articles

Human immunodeficiency virus (HIV) associated non-Hodgkin's lymphomas in Denmark: report of three cases.

Skinhøj P, Ersbøll J, Nissen NI.

Eur J Haematol. 1987 Jul;39(1):71-4.PMID: 3653375 [PubMed - indexed for MEDLINE]Related articles

1 alpha(OH)D3 (ETALPHA) treatment and receptor studies in 16 patients with chronic and myeloproliferative disorders.

Wieslander SB, Mortensen BT, Binderup L, Nissen NI.

Eur J Haematol. 1987 Jul;39(1):35-8.PMID: 3477470 [PubMed - indexed for MEDLINE]Related articles